Janssen makes Denmark a core country for clinical trials
US-based Janssen is pleased with the Danish health authorities, the qualifications of Danish doctors and researchers as well as the initiative Trial Nation – so pleased that the company has made Denmark one of its core countries for clinical trials, which means that the firm will increase its clinical activities in future.
BY ULRICH QUISTGAARD, TRANSLATED BY IDA LØJMAND
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.